Grace Crawford – VP Clinical Quality and Compliance
Grace joined MedImmune in April 2015 as head of the Clinical Quality and Compliance function responsible for the Quality Management Framework that supports Clinical Biologics. Prior to joining MedImmune, Grace spent more than 21 years at ICON where her main focus was leading the Clinical Quality Assurance Department. She is active in the industry, participating in forums such as the Society for Quality Assurance, the AVOCA Quality Consortium and the Linking Leaders Clinical “Quality” Roundtable. Before joining ICON, Grace was a medical technologist in the Clinical Laboratory (Special Chemistry and Immunology) at Bryn Mawr Hospital in Pennsylvania. She earned a Master of Science in clinical microbiology at The Medical College of Pennsylvania.
Joanne Malia is Associate Director of Clinical Documentation Management at Regeneron Pharmaceuticals where she drives operational activities related to the implementation and management of an eTMF and associated clinical document management processes. She serves as the business owner for eTMF implementation across the organization. In this capacity, she interacts with internal senior level management, external vendors, collaboration partners, and clinical study and other internal personnel to ensure compliance with Regeneron business practices and clinical research program objectives.
Prior to March 2017, Joanne was the Director of Clinical Research & Development Process Management at Purdue Pharma she was responsible for research quality, data integrity and continuous improvement in clinical research. At Purdue Pharma, she was responsible for the Trial Master File and FDA submission and inspection readiness beginning in 2008. She and her team worked with a TMF vendor and successfully implemented an eTMF based on the industry standard Reference Model which is currently used by the internal teams and CROs. As part of her inspection readiness responsibilities, she has been actively pursuing quality improvements in site preparation and the TMF.
Joanne received her bachelor’s degree from Notre Dame College in New Hampshire and went on to get her master’s in microbiology from the University of Connecticut in Storrs. Additionally, she attended Lesley College in Cambridge, MA and received a master’s degree in applied management. She has worked in R&D at various biotech, device, CRO and pharmaceutical companies.
Manager, Administration Group
Joy Mehlenbacher-Mohamed – Manager, Administration Group
Joy Mehlenbacher-Mohamed, BSc, is currently working as the manager of the Administration Group at Boehringer Ingelheim Previously she was the as the Clinical Oversight and Quality Documentation Manager at Boehringer Ingelheim and is based in Ontario Canada. She has been working in clinical research for 22 years and with Boehringer Ingelheim since 2003.
Joy’s teams are responsible for overall clinical trial support and the quality of eTMF for inspection readiness.
In addition, her experience includes global TMF governance, global vendor relations and CRO TMF management, white papers on global quality control processes, and regulatory inspection readiness.
Curran Murphy is of has been in the pharmaceutical industry almost 20 years. She began in scientific research and has been in clinical operations for the last decade.
Curran has a passion for operational process improvement. In all of her clinical operations assignments, she has volunteered or been elected as a prominent person to facilitate department process improvements and to make work streams more efficient. Currently, she is the process owner of the Trial Master File Initiative within Cerulean.
Her previous companies include Cerululan Pharma and most recently Syros Pharmaceuticals where she was Associate Director of Clinical Operations. She was also with with Millennium Pharmaceuticals and Alkermes. Curran holds a Bachelor of Administration degree from Syracuse University.
Karen graduated as a pharmacist in South Africa and entered the life science industry working for Eli Lilly. In 1992, she moved into clinical research in the UK with Chiltern International, initially managing the Clinical Development Department across Europe. Latterly she started and globally managed a novel group, EDC Solutions.
In 2007, Karen joined Phlexglobal as Chief Business Development Officer and in 2015 she moved into the role of Vice President, Client Solutions. With her clinical and EDC background, Karen has also taken on a lead role in Phlexglobal’s electronic Trial Master File initiative, to promote, develop and implement support of Client eTMF systems as well as Phlexglobal’s eTMF Solution – PhlexEview.
Karen’s most recent role is that of Chief Strategy Officer where she is focussing on the strategic priorities for the company. Karen focuses on four key areas, being Key Clients, CROs, TMF Expertise and PhlexEview eTMF, in order to support the continued strong growth of Phlexglobal.
Karen also co-chairs the TMF Reference Model, an industry-driven initiative to standardize the content, naming and structure of Trial Master Files.
Bryan Souder is Director, TMF Head at Merck & Co., INC., USA. He has a BS from Radford University, a Six Sigma Greenbelt, and 22 years of clinical trial research experience. His current focus is being TMF Head. Prior to leading the department, Bryan was the eTMF “Global Implementation Lead” Merck & Co., Inc. He has conducted eTMF application & process training in 18 countries and has hosted multiple sponsor inspections.
Ms. Toth has over 18 years of IT experience in the pharmaceutical industry. She joined Daiichi Sankyo in February 2016 after working at a CRO for 8 years within the Trial Master File space.
Ms. Toth is a Steering Committee member for the DIA TMF Reference Model Working Group and on the Board for the Scientific Archivist Group (SAG) as well as on the SAG-GCP Executive Board.
Ms. Toth is a Certified Project Manager (CPM), a trained Six Sigma Green Belt, and is PROSCI certified. She received her Master’s Degree in Clinical Research & Organizational Management from Drexel University, a Bachelor of Arts in Business and Technology from Fairleigh Dickinson University, and has an Associates of Applied Sciences in Computer Systems & Technology from Mercer County Community College. In her spare time, she enjoys family time and watching her kids play soccer, basketball and football.
Associate Manager, Clinical Records
Ivan Walrath – Head of Audit and Inspection Quality
In his capacity as Head of Audit and Inspection Quality, Ivan Walrath is responsible for driving GCP with inspection readiness, audit, management that uses TMF and Operational data. Previously, Ivan was the Business Process Owner for the Trial Master File and Study Execution Processes at Pfizer. As Business Process Owner, he was responsible for end-to-end process design across the entire portfolio of clinical trials including implementation of process, standards and controls,, technology, and measurement.
Ivan has been at Pfizer for more than 23 years in the clinical trial arena, including monitoring, study management, clinical project management and records management, where he worked on the development and implementation of Pfizer’s first electronic Trial Master File in 2000 as well as the more recent implementation of Pfizer’s current TMF process and eTMF system. With his extensive knowledge of clinical trial execution, TMF processes and eTMF systems, Ivan is looked on as an industry leader in this field.
Before joining Pfizer, he coordinated clinical trials in Philadelphia, where he managed trials conducted in depression, anxiety and schizophrenia. He holds a Master of Science degree in Organizational Management from Eastern Connecticut State University and a Bachelor of Arts degree in Psychology from the University of Pennsylvania.
Exec. Director, Site Management Operations, Acquisition Integrations and Clinical Records Management
Alana Wriggins – Exec. Director, Site Management Operations, Acquisition Integrations and Clinical Records Management
Alana has more than 20 years of clinical research experience, and has led both regional and global cross-functional staff across project teams and facilitated numerous process improvement initiatives. She has been involved at the front-line of numerous FDA inspections. In her current role at Allergan, she leads the group responsible for the global oversight of TMF management and archiving, as well as, inspection readiness and acquisition activities. She is also responsible for site management activities in North America. Alana received her Bachelor of Science degree in Nursing from the University of South Carolina and her Master’s degree in Health Science, Clinical Research Administration from George Washington University. She is a member of ACRP and the Regulatory Affairs Professional Society.